On Dec. 3, 1984, the worst industrial accident in history unfolded in India. No punishment meted out has fit the immensity of the wrongdoing
With aviation fanatics keeping a close watch outside aircraft factories, little is secret
With Walmart workers promising their biggest strike, here's how to understand the action on Black Friday
How Anita Sarkeesian is trying to change the $25 billion video game industry
Subsidies from developers can lower interest rates to zero
Holiday gifts for every workstation in life, whether you're fetching coffee, announcing your IPO, or playing tennis all day
Graduate students get paid close to the minimum wage to do high-level coding work for tech companies
A look at how business owners profiled in Bloomberg Businessweek are coping with the latest unrest
San Mateo, Calif.
Founders: Dr. Michael Selley, Dr. Lawrence Steinman, and Dr. Marc Feldmann
VC Investment over the last four quarters: $27 million
Founded in Australia in 2005 and established in the U.S. in 2007, Nuon Therapeutics is a clinical stage company developing oral treatments for multiple sclerosis and rheumatoid arthritis. The six-employee firm, which had previously raised a $5 million Series A round, is continuing development while conserving cash during the downturn, says CEO Rodney Pearlman. "Since we are in clinical stage development, this can be an expensive phase, so we have to ensure we meet our goals while being fiscally responsive to the current environment," he says.
Key to startup success: "Be opportunistic and think outside the box."